[go: up one dir, main page]

ES535923A0 - Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar - Google Patents

Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Info

Publication number
ES535923A0
ES535923A0 ES535923A ES535923A ES535923A0 ES 535923 A0 ES535923 A0 ES 535923A0 ES 535923 A ES535923 A ES 535923A ES 535923 A ES535923 A ES 535923A ES 535923 A0 ES535923 A0 ES 535923A0
Authority
ES
Spain
Prior art keywords
pharmacy
controlled
similar
bioactive agent
uniform delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535923A
Other languages
English (en)
Other versions
ES8607357A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kendall Co
Original Assignee
Kendall Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kendall Co filed Critical Kendall Co
Publication of ES8607357A1 publication Critical patent/ES8607357A1/es
Publication of ES535923A0 publication Critical patent/ES535923A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L39/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions of derivatives of such polymers
    • C08L39/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
    • C08L39/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES535923A 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar Expired ES8607357A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53264383A 1983-09-15 1983-09-15
US06/606,794 US4693887A (en) 1983-09-15 1984-05-03 Microphase separated hydrogels for controlled release of bioactive materials

Publications (2)

Publication Number Publication Date
ES8607357A1 ES8607357A1 (es) 1986-05-16
ES535923A0 true ES535923A0 (es) 1986-05-16

Family

ID=27063895

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535923A Expired ES8607357A1 (es) 1983-09-15 1984-09-14 Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar

Country Status (18)

Country Link
US (1) US4693887A (es)
AT (1) ATA290884A (es)
AU (1) AU577056B2 (es)
BE (1) BE900581A (es)
BR (1) BR8404409A (es)
CA (1) CA1232201A (es)
CH (1) CH666415A5 (es)
DE (1) DE3432573A1 (es)
DK (1) DK410984A (es)
ES (1) ES8607357A1 (es)
FR (1) FR2551976B1 (es)
GB (2) GB2147002B (es)
IT (1) IT1178430B (es)
NL (1) NL8402833A (es)
NO (1) NO843650L (es)
NZ (1) NZ209323A (es)
PT (1) PT79192B (es)
SE (1) SE461502B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3517080A1 (de) * 1985-05-11 1986-11-13 Bayer Ag, 5090 Leverkusen Komponente fuer therapeutische wirkstoffabgabesysteme
IE59361B1 (en) * 1986-01-24 1994-02-09 Akzo Nv Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
US4971790A (en) * 1986-02-07 1990-11-20 Alza Corporation Dosage form for lessening irritation of mocusa
US4867969A (en) * 1986-02-07 1989-09-19 Alza Corporation Hydrogel formulation for administering non-steroidal drugs
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5133992A (en) * 1988-03-21 1992-07-28 Eastman Kodak Company Colloidally stabilized suspension process
US4931287A (en) * 1988-06-14 1990-06-05 University Of Utah Heterogeneous interpenetrating polymer networks for the controlled release of drugs
EP0347145A3 (en) * 1988-06-14 1990-10-24 University Of Utah Research Foundation Heterogeneous interpenetrating polymer networks for the controlled release of drugs
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5270358A (en) * 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
ES2062900B1 (es) * 1991-07-29 1995-07-01 Univ Madrid Nac Educacion Hidrogeles de polimero heterociclico, su procedimiento de obtencion y su utilizacion como pastillas insolubles reguladoras del ph.
WO1993009713A1 (en) * 1991-11-15 1993-05-27 Minnesota Mining And Manufacturing Company Biomedical electrode provided with two-phase composites conductive, pressure-sensitive adhesive
US5352448A (en) * 1992-07-20 1994-10-04 Purdue Research Foundatioin Oral administration of antigens
EP0605705B1 (en) * 1992-07-29 1997-05-21 Baxter International Inc. Pharmaceutical containers and medical devices with hydrophilic protein-compatible surfaces
DE4341156C2 (de) * 1993-12-02 1997-11-13 Wacker Chemie Gmbh Verwendung von in Wasser redispergierbaren Kunststoffdispersionspulvern als Arzneimittelträger
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
DE19622355A1 (de) * 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
US8003705B2 (en) 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US5814329A (en) * 1996-11-12 1998-09-29 Polytherapeutics, Inc. Hydrophilic polystyrene graft copolymer vehicle for intravaginal administration of pharmacologically active agents
DE19753298A1 (de) * 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
JP3406903B2 (ja) 1998-04-27 2003-05-19 サーモディックス，インコーポレイティド 生物活性剤を放出するコーティング
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
AU2707500A (en) 1998-12-04 2000-06-26 Incept Llc Biocompatible crosslinked polymers
ATE432093T1 (de) 2002-03-14 2009-06-15 Medrx Co Ltd Topisches medikament für wunden
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US20040111144A1 (en) * 2002-12-06 2004-06-10 Lawin Laurie R. Barriers for polymeric coatings
WO2005003192A1 (en) * 2003-06-26 2005-01-13 Symyx Technologies, Inc. Synthesis of photoresist polymers
EP1667645A1 (en) * 2003-09-19 2006-06-14 Symyx Technologies Materials for enhanced delivery of hydrophilic active agents in personal care formulations
EP1740235B1 (en) 2004-04-06 2009-07-22 SurModics, Inc. Coating compositions for bioactive agents
WO2007035954A2 (en) * 2005-09-23 2007-03-29 Duramed Pharmaceuticals, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
EP2114298B1 (en) * 2006-02-08 2022-10-19 Medtronic, Inc. Temporarily stiffened mesh prostheses
JP2010519183A (ja) * 2007-02-06 2010-06-03 インセプト エルエルシー 生理溶液の溶出のためのタンパク質の沈殿を用いる重合
CN201075472Y (zh) * 2007-05-28 2008-06-18 富士康(昆山)电脑接插件有限公司 电连接器
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
US8745133B2 (en) * 2008-03-28 2014-06-03 Yahoo! Inc. System and method for optimizing the storage of data
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085168A (en) * 1971-02-22 1978-04-18 Cpc International Inc. Chemically joined, phase separated self-cured hydrophilic thermoplastic graft copolymers and their preparation
US4277582A (en) * 1978-03-03 1981-07-07 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
SU1243627A3 (ru) * 1979-12-05 1986-07-07 Дзе Кендалл Компани (Фирма) Гелеобразующа композици
SE448544B (sv) * 1979-12-05 1987-03-02 Kendall & Co Vattenabsorberande komposition och anvendning derav som berare for ett lekemedel
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
JPS5776046A (en) * 1980-10-27 1982-05-12 Kendall & Co Water absorbing composition

Also Published As

Publication number Publication date
NL8402833A (nl) 1985-04-01
BE900581A (fr) 1985-03-14
NZ209323A (en) 1987-04-30
CA1232201A (en) 1988-02-02
AU3226884A (en) 1985-03-21
AU577056B2 (en) 1988-09-15
GB8423416D0 (en) 1984-10-24
SE461502B (sv) 1990-02-26
IT8448836A1 (it) 1986-03-13
CH666415A5 (de) 1988-07-29
PT79192A (en) 1984-10-01
SE8404568L (sv) 1985-03-16
GB2177708A (en) 1987-01-28
SE8404568D0 (sv) 1984-09-12
US4693887A (en) 1987-09-15
IT1178430B (it) 1987-09-09
NO843650L (no) 1985-03-18
FR2551976B1 (fr) 1988-06-10
DK410984A (da) 1985-03-16
IT8448836A0 (it) 1984-09-13
ATA290884A (de) 1991-07-15
BR8404409A (pt) 1985-07-30
ES8607357A1 (es) 1986-05-16
GB8620117D0 (en) 1986-10-01
DK410984D0 (da) 1984-08-28
DE3432573A1 (de) 1985-04-18
GB2147002A (en) 1985-05-01
PT79192B (en) 1986-08-14
FR2551976A1 (fr) 1985-03-22
GB2147002B (en) 1987-11-11

Similar Documents

Publication Publication Date Title
ES535923A0 (es) Un dispositivo para la entrega controlada y uniforme de un farmaco, agente bioactivo, o similar
NO883918L (no) Beleggsformulering for bioaktive stoffer med kontrollert frigjoering.
ES517444A0 (es) Procedimiento para obtener medicamentos altamente solubles por atomizacion en presencia de un estabilizante y un agente inhibidor de formacion de cristales.
IT8667329A0 (it) Dispositivo osmotico comprendente mezzi per regolare la durata iniziale di erogazione di un agente medicinale da detto dispositivo
ES511433A0 (es) "procedimiento de preparacion de productos utiles particularmente en medicamentos utilizables para el tratamiento de melanomas".
IT1226741B (it) Strutture assorbenti con agente gelificante e articoli assorbenti contenenti tali strutture.
DE3378917D1 (en) Hypocholesterolemically and/or hypotriglyceridemically active products
PH21847A (en) Phenalkoxyalkyl-and phenoxyalkyl-substituted oxiranecarboxylic acids,their use and medicaments containing them
EP0304802A3 (en) Pharmaceutical composition and the use thereof
ES1007668Y (es) Dispositivo con al menos un recipiente para la conservacion y entraga de una sustancia.
DE68904753D1 (de) Kaeltemittelbehandlungs- und fuellsystem.
ES2013727B3 (es) Procedimiento para la fabricacion de articulos de cerdas y articulos de cerdas fabricadas por dicho procedimiento.
IT1150191B (it) Agente di proliferazione per bifidobatteri
DK432289A (da) Vandfortyndbart, lufttoerende belaegningsmiddel og dets anvendelse
ES1009893Y (es) Dispositivo para la acogida y cesion de un agente de tratamiento.
NO894725D0 (no) Mineralfiber-basert komposittmateriale, innretning for fremstilling derav og materialets anvendelse.
ES509570A0 (es) Perfeccionamientos en un dispositivo de aplicacion de un liquido para el tratamiento o la distribuicion de vegetales".
ES295960Y (es) Dispositivo osmico para la descarga controlada de un agente.
EP0084053A4 (en) Medicines and the use of Sn or Cr protoporphyrin for its manufacture.
EP0369035A4 (en) Agent for treating pancreatitis or the like
EP0059346A3 (en) Therapeutic agent and the use thereof
IT8820194A0 (it) Procedimento di dosaggio di sostanze liquide o pastose e impianto per la realizzazione ditale procedimento.
GB2098506B (en) Drug coated materials
ES519265A0 (es) Dispositivo para la produccion y el deposito continuos de bucles de hilado.
NL192974B (nl) Kleiproduct voor therapeutische toepassing, werkwijze voor de bereiding ervan en therapeutisch product dat het bevat.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201